VirusExpress® Lentivirus Production Platform

Updated LV Feature

You’re developing lifesaving gene-modified cell therapies and need to manufacture lentiviral vector as quickly as possible. But scale-up and regulatory hurdles make the path to the clinic slow and labor intensive.

We're here to help.

The VirusExpress® Lentiviral Production Platform offers a transfection-based solution using a suspension cell line, chemically defined medium, and a process with proven performance at scale.

Draw on our 30+ years of viral vector manufacturing experience and a platform that can dramatically reduce your process development and scale-up time to speed your therapy to patients.

Find out how you can draw on our experience to get on the fast track through production.